Vitamin D and Cancer

The following chapters provide excellent and comprehensive discussions of the potential role of vitamin D based therapies in breast, colorectal, prostate cancer and leukemia and myelodysplastic syndromes. These chapters also point out that the focus on these diseases is largely determined by the int...

Full description

Bibliographic Details
Other Authors: Trump, Donald L. (Editor), Johnson, Candace S. (Editor)
Format: eBook
Language:English
Published: New York, NY Springer New York 2011, 2011
Edition:1st ed. 2011
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 01643nmm a2200301 u 4500
001 EB000362426
003 EBX01000000000000000215478
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9781441971883 
100 1 |a Trump, Donald L.  |e [editor] 
245 0 0 |a Vitamin D and Cancer  |h Elektronische Ressource  |c edited by Donald L. Trump, Candace S. Johnson 
250 |a 1st ed. 2011 
260 |a New York, NY  |b Springer New York  |c 2011, 2011 
300 |a XI, 342 p  |b online resource 
653 |a Cancer research 
653 |a Nutrition    
653 |a Nutrition 
653 |a Pharmacology 
653 |a Cancer Research 
653 |a Pharmacology/Toxicology 
700 1 |a Johnson, Candace S.  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
856 4 0 |u https://doi.org/10.1007/978-1-4419-7188-3?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 614.5999 
520 |a The following chapters provide excellent and comprehensive discussions of the potential role of vitamin D based therapies in breast, colorectal, prostate cancer and leukemia and myelodysplastic syndromes. These chapters also point out that the focus on these diseases is largely determined by the interests and expertise of the outstanding scientists who have chosen to pursue vitamin D based cancer therapeutics. To our knowledge, every tumor type ever evaluated has shown some biochemical and antiproliferative response to vitamin D. Similarly, vitamin D analogues, especially calcitriol, potentiate almost every cytotoxic agent with which combination therapies have been tested